Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming
Muhua Chen, Chunfeng Zhang, Wei Liu, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2354-2369
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

HCC-Related lncRNAs: Roles and Mechanisms
Mimansha Shah, Devanand Sarkar
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 597-597
Open Access | Times Cited: 17
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 49
Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress
Chen-Yu Hu, Zechang Xin, Xiaoyan Sun, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 24
Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma
Yi Fu, Anfeng Si, Xindong Wei, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming
Shizhen Li, Mingjing Peng, Shiming Tan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
LINC00629, a HOXB4‐downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c‐Myc
Jia Liu, Yuan Xiao Zhu, Huan Wang, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 804-819
Open Access | Times Cited: 5
LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis
Zechang Xin, Chen-Yu Hu, Chunfeng Zhang, et al.
Redox Biology (2024) Vol. 77, pp. 103362-103362
Open Access | Times Cited: 5
ZNF384 and m6A methylation promote the progression of hepatocellular carcinoma by regulating the interaction between LINC00342 and DAPK1
Shujia Kong, Jiaxun Li, Xin Pan, et al.
Cellular Signalling (2025) Vol. 129, pp. 111666-111666
Closed Access
IGF2BP1/AIFM2 axis regulates ferroptosis and glycolysis to drive hepatocellular carcinoma progression
Wei Peng, Jie Liang, Xuanlv Qian, et al.
Cellular Signalling (2025), pp. 111660-111660
Closed Access
Long non-coding RNA LINC01532 sustains redox homeostasis and accelerates lenvatinib resistance in hepatocellular carcinoma
Yang Hu, Muhua Chen, Shiqi Sun, et al.
Journal of Advanced Research (2025)
Open Access
The role of noncoding RNAs in metabolic reprogramming of cancer cells
Amir Safi, Mohammadreza Saberiyan, Mohammad‐Javad Sanaei, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han Qin, Mengchen Wang, Xi Dong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Amino acid metabolism regulated by lncRNAs: the propellant behind cancer metabolic reprogramming
Qifan Hu, Yutong Li, Dan Li, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability
Xu Zhao, Jinbo Chen, Chunyu Zhang, et al.
Cellular Signalling (2023) Vol. 111, pp. 110839-110839
Open Access | Times Cited: 10
Uncovering SIRT3 and SHMT2-dependent pathways as novel targets for apigenin in modulating colorectal cancer: In vitro and in vivo studies
Nourhan M. Abdelmaksoud, Ahmed I. Abulsoud, Tamer M. Abdelghany, et al.
Experimental Cell Research (2024) Vol. 441, Iss. 1, pp. 114150-114150
Closed Access | Times Cited: 3
Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications
Yitong Liu, Ping Leng, Yan Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15759-15759
Open Access | Times Cited: 14
CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma
Zuoming Xu, Yinghong Wu, Meng Yang, et al.
Experimental Cell Research (2023) Vol. 426, Iss. 1, pp. 113513-113513
Closed Access | Times Cited: 8
KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway
Shimin Lu, Yinghui Liu, Shan Tian, et al.
Experimental Cell Research (2023) Vol. 426, Iss. 1, pp. 113564-113564
Closed Access | Times Cited: 7
Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma
Jiaqi Sheng, Enjun Lv, Limin Xia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113327-113327
Closed Access | Times Cited: 11
The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma
Chunfeng Zhang, Yang Yang, Kun Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 11
Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma
Hung Huynh, Wai Har Ng, Khee Chee Soo
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 17-17
Open Access | Times Cited: 5
ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma
Weichen Wang, Dongquan Liu, Jiaming Yao, et al.
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 1
FOXM1 Upregulates O-GlcNAcylation Level Via The Hexosamine Biosynthesis Pathway to Promote Angiogenesis in Hepatocellular Carcinoma
Xiaorong Zhang, Yifan Zhong, Qing Yang
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 2767-2785
Closed Access | Times Cited: 1
Inhibiting lncRNA NEAT1 Increases Glioblastoma Response to TMZ by Reducing Connexin 43 Expression
Junlin Liang, Jiaxiu Xie, Junhui He, et al.
Cancer Reports (2024) Vol. 7, Iss. 10
Open Access | Times Cited: 1
ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis
Rui Song, Juntao Huang, Chenglei Yang, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 8381-8398
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top